Aminolevulinic Acid Hydrochloride

• IMPALA Protocol: Intrapleural Photodynamic Therapy by Video-Assisted Thoracoscopy Followed by Anti-PD-1 NIVOLUMAB in Patients With Malignant… Recruiting
  2024-514103-33-00 Phase II 1 country Centre Hospitalier Universitaire De Lille
• 5-Aminolevulinic Acid (5-ALA) for Intraoperative Imaging in Patients with Ovarian Cancer – a Single Center Feasibility Study (ILLUMINATE) Recruiting
  2024-510614-33-00 Phase II 1 country Rheinische Friedrich-Wilhelms-Universitaet Bonn
• A pilot study of the safety and tolerability of oral administration of PD L 506 and the subsequent diagnostic value of porphyrin concentrati… Recruiting
  2023-508668-31-00 Phase II 1 country Photonamic GmbH & Co. KG
• Phase I/II dose escalation trial of radiodynamic therapy (RDT) with 5-Aminolevulinic acid in patients with first recurrence of glioblastoma Recruiting
  2024-517651-12-00 Phase I/II 1 country Universitaet Muenster
• An interventional, multicenter, and international phase 1/2, light-dose-escalation study to investigate the safety and feasibility of intrao… Ended
  2025-520563-41-00 Phase I (FiH) 1 country Hemerion Therapeutics
• Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With Ultrasound for Sonodynamic Therapy (SDT) in Patients With Ne… Ended
  2023-509238-20-00 Phase II 1 country Universitaet Muenster
• Evaluation of the feasibility of PD L 506 for stereotactic interstitial photodynamic therapy (iPDT) in adult patients with newly diagnosed s… Ended
  2023-510024-79-00 Phase II 1 country Photonamic GmbH & Co. KG
• Clinical safety study on 5-Aminolevulinic acid (5-ALA) in children and adolescents with brain tumors Ended
  2024-517575-20-00 Phase II 2 countries Universitaet Muenster

Showing 1–8 of 8 trials